Silexion Therapeutics Stock Forecast

SLXN's stock price has decreased by -97.79% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Silexion Therapeutics stock have an average target of $60, which predicts a 2,172.73% increase from the current stock price of 2.64.

Price Target: $60 (+2,172.73%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$60	$60	$60	$60
Change	+2172.7%	+2172.7%	+2172.7%	+2172.7%

Analyst Ratings

The average analyst rating for Silexion Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Mar '26	Apr '26	Jun '26
Strong Buy	0	0	1	1	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Naz Rahman Maxim Group	Maxim Group	Buy Reiterates $60 → $6	Buy	Reiterates	$60 → $6	+127.27%	Jun 24, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

Fiscal Year	FY 2012	FY 2013	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2012	Dec 31, 2013	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-953.00K	-1.36M	-4.68M	-12.57M	-11.63M	-13.67M
Net Income	-938.00K	-1.36M	-4.94M	-16.44M	-11.91M	-13.66M
Free Cash Flow	-	-305.63K	-	-2.41M	-6.51M	-19.13M
No. Analysts	-	-	-	-	-	2

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-